| Description | S1R agonist 2 is a selective S1R agonist with a Ki of 88 nM for S2R and 1.1 nM for S1R and is protective against ROS and NMDA-induced neurotoxicity. |
| In vitro | S1R agonist 2 (Compound 8b; 0.1-5 μ M) Both can significantly increase the growth of Neurite induced by nerve growth factor (NGF) in a dose-dependent manner.[1] The concentration of S1R agonist 2 (24 hours) in SHSY5Y cells is 1 μ M has a significant inhibitory effect on cell damage induced by Rotenone.[1] S1R agonist 2 (0.1-5 μ M; 24 hours) Neuroprotective effect on NMDA stimulation in SHSY5Y cells.[1] S1R agonist 2 (0-10 μ M; 24-72 hours) has no cytotoxicity to A549, LoVo, and Panc-1 cells.[1] |
| Target activity | σ1 receptor:1.1 nM (Ki), σ2 receptor:88 nM (Ki) |
| molecular weight | 309.45 |
| Molecular formula | C21H27NO |
| CAS | 150085-21-5 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year |
| Solubility | DMSO: 50 mg/mL (161.58 mM) |
| References | 1. Linciano P, et al. Novel S1R agonists counteracting NMDA excitotoxicity and oxidative stress: A step forward in the discovery of neuroprotective agents. Eur J Med Chem. 2023;249:115163. |